Licensable university IP
Immuno imaging agent for use with antibody-drug conjugate therapy
Immuno imaging agent for use with antibody-drug conjugate therapy is marketed for licensing by Stanford University (OTL). It is documented in US patent US 9,844,607. The current assignee of record is Sanofi SA. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2034-04-09. Note: the patent's assignee of record is Sanofi SA, not Stanford University (OTL); confirm that Stanford University (OTL) can license it before relying on this listing.
The patent's current assignee of record is Sanofi SA, which differs from the marketing institution (Stanford University (OTL)). Confirm licensing rights with the assignee of record before relying on this listing.
Patent picture
| Field | Value | Reliability | Source |
|---|---|---|---|
| US patent | US 9,844,607 | High | Google Patents |
| Patent title | Immuno imaging agent for use with antibody-drug conjugate therapy | High | Google Patents |
| Current assignee | Sanofi SA | Good | Google Patents |
| Original assignee | Sanofi SA | Good | Google Patents |
| Legal status | Active | Moderate | Google Patents |
| Filing date | 2014-02-05 | High | Google Patents |
| Priority date | 2013-02-05 | High | Google Patents |
| Publication date | 2017-12-19 | High | Google Patents |
| Expected expiration | 2034-04-09 | Moderate | Google Patents |
- High 90% and up
- Good 80 to 89%
- Moderate 70 to 79%
Legal status is Google Patents' automated indicator, not a legal determination.
Joined to US 9,844,607 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.
Original listing
This technology is marketed for licensing by Stanford University (OTL). View the original listing.